$20M sweet spot round size
Most of their 3 investments are in rounds between $19M and $21M
2014
Artizan Biosciences, Inc. raised $19M on March 1, 2021
Investors: Elm Street Ventures, Osage University Partners (OUP) and Biohaven Pharmaceuticals
Kleo Pharmaceuticals Inc. raised $21M on November 14, 2018
Investors: Biohaven Pharmaceuticals
Kleo Pharmaceuticals Inc. raised undisclosed on September 1, 2016
Investors: Biohaven Pharmaceuticals
$80M
from 4 investors over 4 rounds
Biohaven Pharmaceuticals raised $80M on November 1, 2016
Investors: Osage University Partners (OUP), RA Capital Management, L.P., Vivo Capital and Venrock